Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 04-2015 | 04-2014 | 04-2013 | 04-2012 | |
| Sales | 0 | 49 | 289 | 1,234 | 415 |
| Cost of Goods | N/A | N/A | 130 | 43 | 51 |
| Gross Profit | N/A | 49 | 159 | 1,191 | 364 |
| Operating Expenses | 0 | 14,866 | 16,900 | 6,423 | 8,635 |
| Operating Income | N/A | -14,817 | -16,611 | -5,189 | -8,220 |
| Interest Expense | 0 | 49 | 2,212 | 4,239 | 7,412 |
| Other Income | 0 | 784 | -718 | 12 | -80 |
| Pre-tax Income | 0 | -14,082 | -19,542 | -9,416 | -15,712 |
| Net Income Continuous | N/A | -14,082 | -19,542 | -9,416 | -15,712 |
| Net Income | $N/A | $-14,082 | $-19,542 | $-9,416 | $-15,712 |
| EPS Basic Total Ops | N/A | -16,000.00 | -86,720.00 | -201,280.00 | -387,840.00 |
| EPS Basic Continuous Ops | N/A | -16,048.79 | -66,795.42 | -182,609.50 | -387,960.70 |
| EPS Diluted Total Ops | N/A | -16,000.00 | -86,720.00 | -213,760.00 | -450,240.00 |
| EPS Diluted Continuous Ops | N/A | -16,048.79 | -66,795.42 | -171,293.70 | -362,245.80 |
| EBITDA(a) | $N/A | $-13,994 | $-16,461 | $-5,040 | $-8,014 |